Last reviewed · How we verify
NCT05509738: Text4US
Feasibility of Text4US Program
NA trial testing SMS Text Messaging in Reminder Systems in 2 participants. Terminated before completion.
6 March 2023
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 2 |
| Start date | 17 November 2022 |
| Primary completion | 6 March 2023 |
| Estimated completion | 6 March 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SMS Text Messaging
Conditions studied
- Reminder Systems — all drugs for Reminder Systems →
- Text Messaging — all drugs for Text Messaging →
- Urinary Dysfunction — all drugs for Urinary Dysfunction →
- Urinary Bladder — all drugs for Urinary Bladder →
Sponsor
Stanford University
Who can join
18 and older, any sex, with Reminder Systems or Text Messaging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pediatric Lower Urinary Tract Symptoms (pLUTS) is common in school-age children and can negatively impact the quality of their life. Although at least 50% of children with pLUTS can improve through behavioral changes, how to support parents in helping their children adopt healthy bladder behaviors remains unrevealed. To solve this problem, the investigators developed an early model of a text message-based healthcare assistant. The aim of this study is to examine the feasibility of the text message-based healthcare assistant in pLUTS care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05509738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SMS Text Messaging
Trials testing the same drug.
- NCT04446910 — Using Technology to Reduce Youth Substance Use · NA · completed
- NCT03185741 — Regimen Education and Messaging in Diabetes (REMinD) · NA · completed
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509738 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing